InvestorsHub Logo
Followers 8
Posts 1379
Boards Moderated 0
Alias Born 03/27/2013

Re: invest2992 post# 48334

Tuesday, 04/28/2015 10:50:02 AM

Tuesday, April 28, 2015 10:50:02 AM

Post# of 426490
The problem as I see it is that FDA will not approve an expansion of Vascepa label until some time in 2019. This is completely unacceptable, but what can we, as investors, and Amarin do to get around the FDA? I know the answer, but does the company have the resolve to do it. 1st Amendment challenge.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News